3 results about "Esophageal reflux" patented technology

The present application relates to the field of food technology, and specifically discloses a composition for reducing gastroesophageal reflux in individuals, a preparation method and application thereof. The composition for reducing gastroesophageal reflux in individuals comprises beta-defensin 1, lysozyme and lactoperoxidase. The present application constructs a multi-target synergistic intervention mechanism combining physical protection, secretion regulation and tissue repair through the compounding of four core components, which can comprehensively block the occurrence and development of gastroesophageal reflux. Lactadherin constructs a physical barrier to reduce the risk of reflux dynamics from the source; MLCT precisely regulates gastric acid secretion to reduce chemical stimulation; HMO complex IgG strengthens the mucosal immune barrier and promotes damage repair. The above composition is applied to products for reducing gastroesophageal reflux in individuals, and multi-target synergistic effect is achieved, realizing a full-chain closed-loop intervention from prevention, relief to repair, and significantly improving the clinical improvement effect.

The present application relates to the field of food technology, and specifically discloses a composition for reducing gastroesophageal reflux in individuals, a preparation method and application thereof. The composition for reducing gastroesophageal reflux in individuals comprises lactadherin, medium-long chain triglyceride, human milk oligosaccharide and immunoglobulin G. The present application constructs a multi-target synergistic intervention mechanism combining physical protection, secretion regulation and tissue repair through the compounding of four core components, which can comprehensively block the occurrence and development of gastroesophageal reflux. Lactadherin constructs a physical barrier to reduce the risk of reflux dynamics from the source; MLCT precisely regulates gastric acid secretion, reducing chemical stimulation; HMO compound IgG strengthens the mucosal immune barrier and promotes damage repair. The above composition is applied to products for reducing gastroesophageal reflux in individuals, and multi-target synergistic effect is achieved, realizing the whole-chain closed-loop intervention from prevention, relief to repair, and significantly improving the clinical improvement effect.

The present application relates to the field of traditional Chinese medicine preparation, and discloses a traditional Chinese medicine composition for relieving esophageal reflux cough, which comprises a first extraction component and a second extraction component, wherein the first extraction component is obtained by group extraction of perilla leaf and perilla stem, and the second extraction component is obtained by group extraction of rhizoma coptidis, prepared pinellia, evodia and licorice root.The two groups of raw medicinal materials are respectively decocted, filtered and concentrated to obtain the corresponding extraction components, which are then mixed to form the traditional Chinese medicine composition, which can be further prepared into oral liquid, granules, capsules, pills or powders.The present application is composed of six kinds of raw medicinal materials and prepared by group extraction and recombination, so that the composition is clear in composition and preparation process, and is suitable for preparing a medicine for relieving gastroesophageal reflux cough.